Axalbion

Axalbion is a clinical-stage pharmaceutical company developing TRPM8 agonists for the treatment of chronic cough and dry eye syndrome. Founded in December 2016, the company is headquartered in Manchester, UK, a region renowned for its excellence in respiratory research centers, with offices in Lausanne, Switzerland, and Mountain View, California.